Liminatus Pharma LIMN
NASDAQ LIMN
$3.73 -0.18 (-4.60%)
At close: Sep 30, 2026 · 4:00 PM EDT

Liminatus Pharma (LIMN) Accounts Payables (2024 - 2026)

Updated

Liminatus Pharma (LIMN) reported Accounts Payables of $655,089 for Q2 2026, up 51.7% from $431,873 a year earlier and up 23.7% from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Accounts Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, Liminatus Pharma posted Accounts Payables of $582,234, down 60.7% from FY2024.

  • By year, Accounts Payables came in at $1.48 million in FY2024.
  • The Q2 2026 figure ranks as the highest quarterly Accounts Payables since Q4 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $529,778 (Q1 2026), $582,234 (Q4 2025) and $559,171 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Liminatus Pharma 4.18 Mn 4.18 Mn - 655,089.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 655,089.00
Mar 31, 2026 529,778.00
Dec 31, 2025 582,234.00
Sep 30, 2025 559,171.00
Jun 30, 2025 431,873.00
Dec 31, 2024 1.48 Mn
API Access

Liminatus Pharma Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=LIMN&period=max&api_key=YOUR_API_KEY